Related Experiment Video
Updated: May 10, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
Does a patent foramen ovale influence cognitive function in dialysis patients?
Sudhakar George1, Stephen Holt, Nick Medford
1Clinical Investigations and Research Unit, Brighton and Sussex University Hospitals, Brighton, UK. sudhakargeorge@gmail.com
Insights
Cognitive decline is common in dialysis patients. While a patent foramen ovale (PFO) is a potential factor, it showed minimal impact on cognitive decline over one year in hemodialysis patients.
Area of Science:
- Nephrology
- Neurology
- Cardiology
Background:
- Patients undergoing dialysis exhibit diminished cognitive function compared to controls.
- Cerebral microembolisation via a patent foramen ovale (PFO) is a suspected cause.
Purpose of the Study:
- To assess cognitive decline in hemodialysis (HD) and peritoneal dialysis (PD) patients.
- To investigate the influence of PFO on cognitive decline in dialysis patients.
Main Methods:
- Cognitive testing performed on HD and PD patients.
- Transthoracic echocardiography used to detect PFO.
- One-year follow-up to compare cognitive changes based on PFO presence and dialysis type.
Main Results:
- 80 patients (51 HD, 29 PD) were studied; 21% had a PFO.
- 83% of patients experienced cognitive decline over one year.
- PD patients showed faster cognitive decline than HD patients; PFO presence had minor effects.
Conclusions:
- Dialysis patients experience rapid and widespread cognitive decline.
- The impact of PFO on cognitive decline over one year was subtle.
- PFO presence should not deter patients from choosing hemodialysis due to concerns about microembolisation.
Background:
Patients with chronic kidney disease on dialysis treatment have poorer cognitive function than age- and sex-matched controls. One proposed mechanism is cerebral microembolisation due to material from the dialysis circuit crossing a patent foramen ovale (PFO).
Methods:
Cognitive testing was carried out in haemodialysis (HD) patients and peritoneal dialysis (PD) patients. Transthoracic echocardiography was used to identify PFO. Follow-up testing 1 year later enabled comparison of cognitive decline between patients with and without a PFO, and between those undergoing different dialysis modalities.
Results:
80 patients (aged 60.4 ± 15.0 years) were recruited (51 HD patients and 29 PD controls). A PFO was found in 21% of patients. 83% of dialysis patients suffered a decline in one or more cognitive function tests over 1 year. There was a significant difference in only one test between HD patients with or without a PFO. PD patients showed a more rapid cognitive decline than those on HD.
Conclusions:
Cognitive decline in dialysis patients is rapid and affects most patients. The presence of a PFO made only subtle differences to the rates of cognitive decline during 1 year of follow-up. Patients with a PFO should not be prevented from considering HD because of concerns of cerebral decline due to microembolisation.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Peritoneal Dialysis III: Nursing Management
Hemodialysis III: Nursing Management
Cerebral Edema ll: Pathophysiology
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

